Literature DB >> 11696427

In vivo imaging of physiological angiogenesis from immature to preovulatory ovarian follicles.

B Vollmar1, M W Laschke, R Rohan, J Koenig, M D Menger.   

Abstract

To develop a model for the study of physiological angiogenesis, we transplanted ovarian follicles onto striated muscle tissue and analyzed the process of microvascularization in vivo using repeated fluorescence microscopy. Follicles were mechanically isolated from unstimulated as well as pregnant mare's serum gonadotropin (PMSG)- or PMSG/luteinizing hormone (LH)-stimulated Syrian golden hamster ovaries and were transplanted as free grafts into dorsal skinfold chambers of untreated or synchronized hamsters. Follicles lacking thecal cell layers did not vascularize regardless whether harvested from unstimulated or PMSG-stimulated animals, but underwent granulosa cell apoptosis, as indicated in vivo by nuclear condensation and fragmentation of bisbenzimide-stained follicular tissue. In contrast, all follicles at 48 hours after PMSG treatment with a multilayered thecal shell exhibited initial signs of angiogenesis within 3 days. Vascularization was completed within 7 to 10 days, comprising a dense glomerulum-like microvascular network. Nature and extent of vascularization of follicles harvested at 72 hours after either PMSG or PMSG/LH treatment did not notably differ from each other when transplanted into the respective synchronized animals. However, follicles with PMSG/LH treatment revealed significantly larger microvessel diameters and higher capillary blood perfusion compared to follicles with sole PMSG treatment, probably reflecting the adaptation to the increased functional demand upon the LH surge. Using the unique experimental approach of ovarian follicle transplantation in the dorsal skinfold chamber of Syrian golden hamsters, we could show in vivo the developmental stage-dependent vascularization of follicular grafts with sustained potential to meet their metabolic demand by increased blood perfusion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696427      PMCID: PMC1867040          DOI: 10.1016/S0002-9440(10)63013-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Ovarian microvasculature in normal and hCG stimulated rabbits. A study of vascular corrosion casts with particular regard to the interstitium.

Authors:  G Macchiarelli; S A Nottola; E Vizza; A Kikuta; T Murakami; P M Motta
Journal:  J Submicrosc Cytol Pathol       Date:  1991-07

2.  An enzymatic method for dissociation of intact follicles from the hamster ovary: histological and quantitative aspects.

Authors:  S K Roy; G S Greenwald
Journal:  Biol Reprod       Date:  1985-02       Impact factor: 4.285

3.  Isolation of a nonmitogenic angiogenesis factor from wound fluid.

Authors:  M J Banda; D R Knighton; T K Hunt; Z Werb
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

4.  The nonluteal porcine ovary as a source of angiogenic activity.

Authors:  A Makris; K J Ryan; T Yasumizu; C L Hill; B R Zetter
Journal:  Endocrinology       Date:  1984-11       Impact factor: 4.736

5.  Technical report--a new chamber technique for microvascular studies in unanesthetized hamsters.

Authors:  B Endrich; K Asaishi; A Götz; K Messmer
Journal:  Res Exp Med (Berl)       Date:  1980

6.  Bovine granulosa cells produce basic fibroblast growth factor.

Authors:  G Neufeld; N Ferrara; L Schweigerer; R Mitchell; D Gospodarowicz
Journal:  Endocrinology       Date:  1987-08       Impact factor: 4.736

Review 7.  Intragonadal regulation of follicular maturation.

Authors:  S A Tonetta; G S diZerega
Journal:  Endocr Rev       Date:  1989-05       Impact factor: 19.871

Review 8.  Tumor angiogenesis.

Authors:  J Folkman
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

9.  Preliminary characterization of angiogenic activity in media conditioned by cells from luteinized rat ovaries.

Authors:  J D Rone; A L Goodman
Journal:  Endocrinology       Date:  1990-12       Impact factor: 4.736

Review 10.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

View more
  6 in total

Review 1.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

2.  Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation.

Authors:  M W Laschke; A Elitzsch; C Scheuer; J H Holstein; B Vollmar; M D Menger
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

3.  VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy.

Authors:  Joseph M Rutkowski; Jong Eun Ihm; Seung Tae Lee; Witold W Kilarski; Veronique I Greenwood; Miriella C Pasquier; Alexandra Quazzola; Didier Trono; Jeffrey A Hubbell; Melody A Swartz
Journal:  Am J Pathol       Date:  2013-09-13       Impact factor: 4.307

Review 4.  Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies.

Authors:  Gudrun E Koehl; Andreas Gaumann; Edward K Geissler
Journal:  Clin Exp Metastasis       Date:  2009-02-04       Impact factor: 5.150

5.  A murine model to study vasoreactivity and intravascular flow in lung isograft microvessels.

Authors:  Nora Regelin; Susanne Heyder; Matthias W Laschke; Yalda Hadizamani; Michèle Borgmann; Ueli Moehrlen; René Schramm; Robert Bals; Michael D Menger; Jürg Hamacher
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

Review 6.  Replacement in angiogenesis research: Studying mechanisms of blood vessel development by animal-free in vitro, in vivo and in silico approaches.

Authors:  Matthias W Laschke; Yuan Gu; Michael D Menger
Journal:  Front Physiol       Date:  2022-08-17       Impact factor: 4.755

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.